Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum.

MLA

Louapre, C., et al. “Patients with MS Treated with Immunosuppressive Agents: Across the COVID-19 Spectrum.” Revue Neurologique, vol. 176, no. 6, June 2020, pp. 523–25. EBSCOhost, https://doi.org/10.1016/j.neurol.2020.04.009.

APA

Louapre, C., Maillart, E., Roux, T., Pourcher, V., Bussone, G., Lubetzki, C., & Papeix, C. (2020). Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum. Revue Neurologique, 176(6), 523–525. https://doi.org/10.1016/j.neurol.2020.04.009

Chicago

Louapre, C, E Maillart, T Roux, V Pourcher, G Bussone, C Lubetzki, and C Papeix. 2020. “Patients with MS Treated with Immunosuppressive Agents: Across the COVID-19 Spectrum.” Revue Neurologique 176 (6): 523–25. doi:10.1016/j.neurol.2020.04.009.